Journal of the Academy of Nutrition and Dietetics
ResearchOriginal Research¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors
Section snippets
Study Design and Participant Recruitment
This study was a randomized controlled trial designed to examine the effects of a nine-session (24 hours over 12 weeks), culturally based dietary intervention vs standard written materials on change in F/V and total fat intake among Hispanic breast cancer survivors. Spanish-speaking women with a history of stage 0 to III breast cancer and who were at least 3 months post treatment (surgery, radiation, or chemotherapy; current hormonal therapy allowed) with no evidence of metastatic disease were
Recruitment, Baseline Characteristics, Enrollment, and Retention
Between April 7, 2011 and March 30, 2012, 70 women were randomized into the Intervention (n=34) and Control (n=36) arms. The median number of days between screening and randomization was 43 days. A CONSORT (Consolidated Standards of Reporting Trials) diagram is illustrated in Figure 2. At study enrollment, participants’ scored a mean of 11.6 (standard deviation [SD] 4.2) on the Block Fruit/Vegetable/Fiber Screener, translating to <4 servings of F/V per day (data not shown). At baseline, there
Discussion
The 3-month ¡Cocinar Para Su Salud! culturally based dietary intervention successfully increased the combined intake of F/V among a diverse group of urban Hispanic breast cancer survivors, the majority of whom were of low socioeconomic status, and the dietary changes persisted at 6 months. Future analyses will investigate specific factors related to dietary change. The intervention focused on helping women achieve and maintain the dietary composition guidelines set forth by the AICR and ACS.1, 2
Conclusions
The ¡Cocinar Para Su Salud! study successfully identified an effective method to increase short-term F/V intake among a diverse and under-represented group of Hispanic breast cancer survivors. These dietary changes toward a healthier lifestyle have the potential to improve breast cancer prognosis and cardiovascular and metabolic disease outcomes. The success of this intervention could inform the implementation of community-based nutrition education programs for Hispanic breast cancer survivors
Acknowledgements
The authors thank Lisa Zullig of God's Love We Deliver (New York, NY) for providing nutrition information materials used in the study, Monica Gonzalez, RD, CDN, for her work as the intervention RDN, Ela Guidon for her work as the intervention chef, and all of the study participants for their contributions.
H. Greenlee is an assistant professor, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
References (38)
- et al.
A rapid food screener to assess fat and fruit and vegetable intake
Am J Prev Med
(2000) - et al.
Collection of food and dietary supplement intake data: What we eat in America-NHANES
J Nutr
(2003) - et al.
Family support and asthma outcomes on adolescents: Barriers to adherence as a mediator
J Adolesc Health
(2010) - et al.
Food-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic Community Health Study/Study of Latinos
Am J Clin Nutr
(2014) - et al.
American Cancer Society guidelines on nutrition and physical activity for cancer prevention
CA Cancer J Clin
(2012) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective
(2007)- et al.
Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society's SCS-II
J Clin Oncol
(2008) Prevalence of fruit and vegetable consumption and physical activity by race/ethnicity in the United States, 2005
MMWR Weekly
(2007)- et al.
Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives
(2005) - et al.
Geographic proximity and racial disparities in cancer clinical trial participation
J Natl Compr Canc Netw
(2010)
2011 Population Estimates: National Characteristics
SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations)
PRevalence of childhood and adult obesity in the United States, 2011-2012
JAMA
Health characteristics of adults aged 55 years and over: United States, 2004-2007
Natl Health Stat Report
Summary health statistics for the US population: National Health Interview Survey, 2007
Vital Health Stat
Disparities in breast cancer characteristics and outcomes by race/ethnicity
Breast Cancer Res Treat
Development of a short acculturation scale for Hispanics
Hisp J Behav Sci
Quick assessment of literacy in primary care: The newest vital sign
Ann Fam Med
Cited by (0)
H. Greenlee is an assistant professor, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
A. O. Gaffney is founder and president, Cook for Your Life, New York, NY.
A. C. Aycinena is a clinical research coordinator, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, and a doctoral student, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY.
P. Koch is a research associate professor, Department of Health and Behavior Studies, and executive director, Laurie M. Tisch Center for Food, Education, and Policy in Teachers College, Columbia University, New York, NY.
I. Contento is the Mary Swartz Rose Professor of Nutrition and Education, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY.
W. Karmally is an associate research scientist and director of nutrition, Irving Institute for Clinical and Translational Research, Columbia University, New York, NY.
J. M. Richardson is a data analyst, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
E. Lim is an assistant professor, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
W.-Y. Tsai is a professor, Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
K. Crew is an assistant professor, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY; an assistant professor, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
M. Maurer is an assistant professor, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
K. Kalinsky is an assistant professor, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
D. L. Hershman is an associate professor, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY; an associate professor, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; and a member of the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
Clinicaltrials.gov Identifier: NCT01414062.
Statement of Potential Conflict of Interest: The authors have no potential conflict of interest to disclose.
Supplementary materials: Table 3 is available at www.andjrnl.org
STATEMENT OF POTENTIAL CONFLICT OF INTEREST No potential conflict of interest was reported by the authors.
FUNDING/SUPPORT Supported by National Cancer Institute/National Institutes of Health R21CA152903, and in part by Columbia University's Clinical and Translational Science Award grant no. UL1TR000040 from the National Center for Advancing Translational Sciences/National Institutes of Health.
Clinicaltrials.gov Identifier: NCT01414062.